Sativa Wellness Group Inc. (SWEL.CN)

Get Top Rated Stock Alerts Active Traders Depend On

Sign Up Today For FREE News Driven Alerts

European Union Courts Clear the Way for CBD in Europe

Vancouver, BC – November, 23 2020 – Sativa Wellness Group Inc. (CSE: SWEL) (“Sativa Wellness” or the “Company”) wishes to announce that following the European Court of Justice (the “ECJ”) has ruled that cannabidiol (“CBD”) is not a classified as a narcotic drug, the Company anticipates that the EU FSA will resume their Novel Food process, and subject to the process being agreed, this should be an easy transition for the Company.

 

The ECJ ruling provides that CBD is not classified as a narcotic drug, and that the French ban on hemp derived CBD contradicts European Union (“EU”) law. This decision opens the door for high quality, compliant CBD companies to operate in markets across the EU. Sativa Wellness welcomes this news as the Company operates CBD extraction and production facilities and markets, distributes and sells CBD products throughout the UK and the EU.

 

The Company has embraced the industry regulations in the UK and are on track to have its Novel Food dossier, incorporating an extensive product range, validated by the UK Food Safety Authority ahead of the March 2021 deadline. Following the ECJ ruling, the Company anticipates that the EU FSA will resume their Novel Food process, and subject to the process being agreed, this should be an easy transition for the company to progress towards.

 

Sativa Wellness holds a unique ‘seed to consumer’ position in the market, offering consistent quality control of the cannabinoid, full traceability of ingredients, manufacturing and testing with the added reassurance to the customer that each batch is QR coded which tracks back to its testing report.

 

From this enviable position the Company has developed the ‘Goodbody’ brand – CBD you can trust. Under the Goodbody brand umbrella are the Goodbody Botanicals range for the everyday and pharmaceutical markets and the Goodbody Wellness brand, with its addition of Vitamin D, as a premium CBD brand for the health and beauty spa market.

 

The Goodbody range is available at retailers and direct to the consumer online through Goodbodystore.com and soon available in Europe. As part of our route to market the Company intends to focus on retail listings and selling directly online within Europe.

 

We welcome the news of the EU’s highest court ruling. As a UK and European company that is committed to working with regulators and delivering the highest quality CBD wellness products, this news helps to enable our expansion plans. We currently own extraction and production capabilities in Europe and see this large market as a key driver for our growth for not only our CBD isolate and distillate ingredients, but also for our Goodbody CBD brands!“ said Henry Lees-Buckley, CEO of Sativa Wellness.

 

Further information regarding the Company can be found under the Company’s profile on www.sedar.com.

 

On behalf of the Board of Directors,

 

Henry Lees-Buckley
Chief Executive Officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com
www.sativawellnessgroup.com

Joseph Colliver
Chief Financial Officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com
www.sativawellnessgroup.com

 

Jason Dussault
Investor Relations and Communications
Sativa Wellness Group Inc. jason@sativawellnessgroup.com www.sativawellnessgroup.com

 

Neither the Canadian Securities Exchange nor its Market Regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this release.

 

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Stillcanna’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “anticipates”, “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes” “plan is” or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur”, “will be achieved” or “shortly”. The forward-looking information and forward-looking statements contained herein include, but are not limited to information concerning the European FSA Novel Food process, the interpretation of the ECJ ruling, the authority of the ECJ, the UK FSA application, the parallel nature of the UK FSA and the EU FSA applications, the timing of any applications to EU and UK FSA, the intention to submit applications to the UK and EU FSA, the acceptance by the UK FSA of the Novel Foods dossier, and the Company’s route to market and potential marketing.

 

Although Sativa Wellness believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. In particular, there is no guarantee that the Company will be successful in their applications to the UK and/or EU FSA or be allowed to market CBD products in the European Union. The forward-looking information and forward-looking statements contained in this news release are made as of the date of this press release, and Sativa does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

 

Source:  Sativa Wellness Group Inc.

Sativa Wellness Group Launches COVID Testing Clinic in Store

Vancouver, BC – November 19, 2020 – Sativa Wellness Group Inc. (CSE:SWEL) (“Sativa Wellness” or the “Company“) is pleased to announce that as part of Sativa Wellness’ commitment to safety and wellness in our communities, we are launching a private COVID-19 testing clinic inside our Goodbody Wellness store in Bath on 19th November.

 

The clinic will be providing PCR testing for travel and work, antigen testing (results in 15 minutes) as well as antibody testing for those who want to find out if they have had COVID 19 and to see if they have developed antibodies.

 

Customers book an appointment online, and will attend in-store to self-administer the test guided by a trained medical professional. The Company is already seeing strong demand in pre-bookings for this service.

 

Sativa Wellness provides numerous products to help customers during these challenging times, including our popular Goodbody Wellness CBD with vitamin D, and a complete range of hand sanitiser products designed for use in restaurants, businesses and for personal use, available in-store or online at “https://www.goodbodystore.com“.

 

The UK Government is evaluating a ‘Test to Release’ scheme which is expected to reduce the quarantine period after travelling abroad, by taking a test five or seven days after returning to the UK. However, negative tests are already a requirement when travelling to a number of countries from the UK. Appointments should be made in line with the Government guidelines on when your test is required for travel.

 

The private clinic is designed for people who aren’t presenting symptoms but who need a negative test for travel, work or peace of mind when visiting vulnerable relatives. Anyone with symptoms should instead book an NHS test and follow the Government isolation procedures.

 

The PCR lab test is a swab sent for analysis at an accredited laboratory to test for the presence of COVID-19. A certificate delivered direct via email and SMS is provided to permit travelling and pass immigration. The test is 98% sensitive if the virus is found on the swab and has a 48-72-hour turnaround. The test cost £155.

 

A rapid antigen test is also available, which checks whether you are carrying the COVID-19 virus and could be infectious to others. Sensitivity is 92.5% and Specificity is 99.8%. Results are available in 15 minutes and the test costs £75.

 

Finally, an IgG and IgM rapid antibody test costing £55 is available which tests to see if you have already had COVID-19 and have developed antibodies. The test has an accuracy of 98.3% and results are available in just 15 minutes.

 

According to George Thomas, Managing Director of Goodbody Botanicals, “Our expertise in good health and wellbeing made it an obvious transition to be able to offer COVID testing in our store. The same attention to detail and care has been taken to ensure we can offer the best testing in a safe, calm environment. We hope this service will give people the peace of mind, and proof, required to return to travel, work and visiting friends and family when this is possible”.

 

For more information or to book an appointment visit https://www.goodbodyclinic.com

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

Further information regarding the Company can be found at www.sedar.com.

 

On behalf of the Board of Directors,

Henry Lees-Buckley
Chief Executive Officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com
www.sativawellnessgroup.com
Joseph Colliver
Chief Financial Officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com
www.sativawellnessgroup.com
Jason Dussault
Investor Relations and Communications
Sativa Wellness Group Inc.
jason@sativawellnessgroup.com
www.sativawellnessgroup.com

 

Neither the Canadian Securities Exchange nor its Market Regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this release.

 

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Stillcanna’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes” “plan is” or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur”, “will be achieved” or “shortly”. The forward-looking information and forward-looking statements contained herein include, but are not limited to information concerning the COVID-19 testing clinic, the accuracy of the results of the COVID-19 tests, and the availability of COVID-19 tests.

 

Although Sativa Wellness believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. In particular, there is no guarantee that any sales, profits or revenues will be derived from the agreement with the Health Store. The forward-looking information and forward-looking statements contained in this news release are made as of the date of this press release, and Sativa does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

 

SOURCE: Sativa Wellness Group Inc.

About Sativa Wellness Group


Our vision

 

The Sativa Wellness Group’s goal is to build Europe’s leading CBD Wellness brands, to meet today’s fast evolving consumer expectations. Through full vertical integration of our supply chain, we plan to become one of the premier low-cost producers and high-quality distributors of CBD wellness products in Europe.

 

Our Core Values

Quality

 

We are committed to producing safe, compliant and effective products that are rigorously tested to the highest standards by our in-house laboratory.

 

Brand value

 

To develop brands that meet or exceed consumers fast evolving expectations and needs.

 

Market Access

 

To form direct relationships to consumers and build brand loyalty via wholly owned and operated sales channels.

 

R&D

 

Developing Innovative solutions to meet future consumer demand.

 

Team

 

To build a team of professionals with unparalleled commercial, retail, finance, pharmacological, scientific, governance and regulatory experience.

 


 

With extensive expertise in all areas of hemp cultivation, extraction and formulation, we provide the highest quality, regulatory CBD products on the market today.

 

We own each step of the supply chain from the seed in the ground to the bottling of the product to provide consistent quality in line with regulations. This provides reassurance to our retailers through to our end consumers-CBD you can trust.

 

A CBD Wellness Company

 

With the cultivation and extraction of all cannabinoids, wellness and established brands, existing wholesale and retail sales channels and fully operational state-of-the-art cannabis testing laboratories in Poland and the UK, Sativa Wellness is well positioned within CBD wellness opportunities throughout Europe.

 

Source:  https://sativawellnessgroup.com/

Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty six hundred dollars for Sativa Wellness Group Inc. current news coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF Sativa Wellness Group Inc.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.